Authors: KHOSRAVI E ELENA PP GOLDSCHMIDT P LUYCKX J

Citation: E. Khosravi et al., OCULAR BIOAVAILABILITY OF GANCICLOVIR GEL, AN ANTIHERPETIC FORMULATION, AFTER TOPICAL ADMINISTRATION TO INTACT OR REMOVED CORNEAL EPITHELIUM OF RABBIT EYES, Investigative ophthalmology & visual science, 37(3), 1996, pp. 383-383

Authors: POULIQUEN P ELENA PP MOLECONZE F LUYCKX J LANOUE A GOLDSCHMIDT P

Citation: P. Pouliquen et al., ASSESSMENT OF SAFETY AND LOCAL PHARMACOKINETICS OF A 0.15-PERCENT GELOF GANCICLOVIR (VIRGAN(R)) IN HEALTHY-VOLUNTEERS, Investigative ophthalmology & visual science, 37(3), 1996, pp. 1431-1431

Authors: CHIBRET H GOLDSCHMIDT P POULIQUEN P RONDEPIERRE A DEFEMME A LUYCKX J COQUEL T

Citation: H. Chibret et al., PRESERVATIVES ON THE CELLULAR-SURFACE - NEW TECHNOLOGY (ABAK) ABLE TOCAPTURE IRREVERSIBLY BENZAIKONLUM CHLORIDE (BAK) FROM EYE-DROPS, Investigative ophthalmology & visual science, 37(3), 1996, pp. 2651-2651

Authors: KHOSRAVI E ELENA PP GOLDSCHMIDT P BAUDOIN C LUYCKX J

Citation: E. Khosravi et al., LACK OF CYTOTOXIC EFFECT OF GANCICLOVIR AND ACYCLOVIR ON RABBIT CORNEAL EPITHELIAL-CELLS IN-VITRO, Vision research, 35, 1995, pp. 125-125

Authors: ELENA PP GOLDSCHMIDT P CHAST F SAUVAGEON H LUYCKX J KHOSRAVI E

Citation: Pp. Elena et al., DISTRIBUTION OF GANCICLOVIR IN THE ANTERIOR UVEA AFTER TOPICAL APPLICATION OF 0.15-PERCENT GANCICLOVIR GEL TO INTACT AND HSV-INFECTED EYES OF RABBITS, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1682-1682